PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1378700
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1378700
Interventional Oncology Ablation Market, By Technology, By Indication, By End User, By Geography
The global interventional oncology ablation market is estimated to be valued at US$ 533.7 Million in 2023 and is expected to exhibit a CAGR of 8.7% during the forecast period (2023-2030).
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2022 | Market Size in 2023: | US$ 533.7 Mn |
| Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
| Forecast Period 2023 to 2030 CAGR: | 8.70% | 2030 Value Projection: | US$ 959.5 Mn |
Interventional oncology ablation involves minimally invasive, image-guided procedures to deliver localized cancer treatment. There are two main types of ablation techniques: thermal and non-thermal. Thermal techniques like radiofrequency ablation (RFA), microwave ablation, and cryoablation use heat or cold energy to destroy cancer cells. RFA uses high-frequency electrical currents to generate heat and induce tumor coagulation necrosis. It is widely used for treating liver, kidney, lung, and bone tumors. Microwave ablation applies electromagnetic microwaves to agitate water molecules and produce frictional heat to ablate tissue. Cryoablation freezes and destroys diseased tissue by applying extremely cold temperatures through cooled probes. Non-thermal techniques include irreversible electroporation, which applies short electric pulses to form nanopores in cell membranes, leading to apoptosis. Ablation therapies are minimally invasive, allow for quicker recovery, have fewer side effects, and can be performed repeatedly. They are ideal for inoperable cancers, patients unfit for surgery, and metastatic or recurrent tumors. Ongoing advances focus on improving ablation zone size and precision. Emerging techniques like high-intensity focused ultrasound ablation, photodynamic therapy, and nanoparticle-mediated ablation also show promise in expanding interventional oncology treatment.
Market Dynamics
The constantly increasing number of cancer patients in the market is expected to drive growth of the global interventional oncology ablation market over the forecast period. For instance, in February 2023, according to data published by the American Society of Clinical Oncology (ASCO), there were more than 3.8 million women living with or beyond breast cancer in the U.S. In 2023, an estimated 297,790 women in the U. S. will be diagnosed with invasive breast cancer, 55,720 women will be diagnosed with non-invasive (in situ) breast cancer, and 43,700 deaths (43,170 women and 530 men) from breast cancer will occur in the U.S.
Key features of the study:
- This report provides an in-depth analysis of the global interventional oncology ablation market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global interventional oncology ablation market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Boston Scientific Corporation, Johnson & Johnson, Medtronic Plc, Varian Medical Systems, Inc., EDAP TMS S.A., AngioDynamics, CASCINATION AG, Merit Medical Systems, Inc., STARmed Co., and Biomedical Srl.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global interventional oncology ablation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global interventional oncology ablation market
Interventional Oncology Ablation Market Detailed Segmentation:
- By Technology:
- Radiofrequency Ablation
- Microwave Ablation
- Cryoablation
- Irreversible Electroporation Ablation
- By Indication:
- Liver Cancer
- Kidney Cancer
- Lung Cancer
- Others
- By End User:
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Others
- By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profiles
- Boston Scientific Corporation
- Johnson & Johnson
- Medtronic Plc
- Varian Medical Systems, Inc.
- EDAP TMS S.A.
- AngioDynamics
- CASCINATION AG
- Merit Medical Systems, Inc.
- STARmed Co.
- Biomedical Srl.
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Technology
- Market Snippet, By Indication
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Test Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Interventional Oncology Ablation Market - COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
5. Global Interventional Oncology Ablation Market, By Technology, 2018- 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Radiofrequency Ablation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018- 2030, (US$ Mn)
- Segment Trends
- Microwave Ablation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Segment Trends
- Cryoablation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Segment Trends
- Irreversible Electroporation Ablation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Segment Trends
6. Global Interventional Oncology Ablation Market, By Indication, 2018 - 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Liver Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Segment Trends
- Kidney Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Segment Trends
- Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Segment Trends
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Segment Trends
7. Global Interventional Oncology Ablation Market, By End User, 2018 - 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
8. Global Interventional Oncology Ablation Market, By Region, 2018 - 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Boston Scientific Corporation*
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Johnson & Johnson
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Medtronic Plc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Varian Medical Systems, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- EDAP TMS S.A.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- AngioDynamics
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- CASCINATION AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Merit Medical Systems, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- STARmed Co.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Biomedical Srl
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
10. Section
- References
- Research Methodology
- About us and Sales Contact
